株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

世界・米国・欧州の再生医療市場:需要分析・機会評価

Global, U.S. & Europe Regenerative Medicines Market Demand Analysis & Opportunity Evaluation, 2019-2027

発行 Research Nester 商品コード 915931
出版日 ページ情報 英文 153 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
世界・米国・欧州の再生医療市場:需要分析・機会評価 Global, U.S. & Europe Regenerative Medicines Market Demand Analysis & Opportunity Evaluation, 2019-2027
出版日: 2019年09月19日 ページ情報: 英文 153 Pages
概要

世界の再生医療市場は、医療費の増加や効果的な治療に対する需要の高まり、技術発展、慢性疾患の治療における幹細胞技術の採用などによって当市場の成長が促進されると予測されています。

当レポートでは、世界の再生医療市場を調査し、市場の概要、市場動向、技術・原料・用途・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および課題の分析、規制環境、リスク分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

イントロダクション

  • 市場定義
  • 製品定義
  • 調査目的
  • 調査手法

エグゼクティブサマリー

世界の再生医療市場:市場力学

  • 市場の成長要因
  • 市場の課題
  • 市場動向
  • 市場機会

世界の再生医療市場

  • 市場概要 - 市場規模の推移と予測
  • 市場区分:セグメント別
  • 技術別
  • 原料別
  • 用途別
  • エンドユーザー別

米国の再生医療市場

  • 市場概要 - 市場規模の推移と予測
  • 市場区分
  • 技術別
  • 原料別
  • 用途別
  • エンドユーザー別

欧州の再生医療市場

  • 市場概要 - 市場規模の推移と予測
  • 市場区分
  • 技術別
  • 原料別
  • 用途別
  • エンドユーザー別

産業分析

政策・規制環境

リスク分析

競合情勢

主要企業のプロファイル

目次

The global regenerative medicine market is estimated to grow on the back of rising healthcare expenditure with increasing demand for efficient disease treating practices coupled with growing technological developments and discoveries. The world bank reported a rise in global current health expenditure (% GDP) from 9.453% in 2011 to 10.023% in 2016.

Additionally, global regenerative medicines market is estimated to grow at a robust rate on the back of increasing adoption of stem cell technology to address the rising prevalence of chronic diseases. Moreover, emerging applications of gene therapy in regenerative medicines for tackling infectious diseases such as, malaria, HIV, tuberculosis and influenza or to target angiogenesis during cardiac surgery is leading to subsequent expansion in usage base of regenerative medicines around the globe.

Increasing incidences of chronic oncogenic diseases such as cancer with an estimated new cases of 18.1 million in 2018 as per International Agency for Research on Cancer (IARC), is anticipated to display rapid growth in application of regenerative medicines in the upcoming years. Additionally, increasing application of regenerative medicines to treat auto-immune hepatitis, is expected to back the rampant growth in the upcoming years. Moreover, government initiatives to eliminate chronic diseases is anticipated to aid the growth in upcoming years. For instance, World Health Organization (WHO) launched an initiative to eliminate hepatitis completely by 2030. Furthermore, Regenerative medicines comprising blood stem cell implants can be used to restore healthy bone marrow in patients with leukemia. Besides, experiments in the gene therapy segment to explore benefits for various other medical applications, is expected to propel considerable growth in the regenerative medicines market in the upcoming years.

Application of regenerative medicines in tissue-engineering cartilages, modifying chondrocytes, and other tissue engineering technologies for treating traumatic and degenerative joint diseases is estimated to drive the market growth in the upcoming years. Additionally, increasing use of regenerative medicines in hepatocyte transplants for chronic liver disease treatments and liver failure conditions is propelling an exponential growth in the global market. Moreover, increasing use of poly-hemoglobin blood substitute produced through regenerative medicines to treat conditions of blood contamination or blood shortages is further propelling growth in the utilization of regenerative medicines in the hospitals, blood banks and research institutes.

Tissue engineering is a field majorly focused on development of tissue and organ substitutes by controlling biological, biophysical and/or biomechanical parameters in the laboratory. Of late, tissue engineering has gained popularity on the back of it's utilization to bioengineer implantable devices, reconstitute decellularized organs, and manufacture organs using 3D bio-printing.

Additionally, rising geriatric population across the globe holds immense opportunities for regenerative medicines in the upcoming years. According to World Bank, population aged 65 and above increased from 7.64% in 2010 to 8.926% of the overall population in 2018. Moreover, change in climatic conditions and increase in sedentary lifestyles has led to drastic demographic changes in developed and developing countries, resulting in growing number of disease cases associated with aging. This aspect is attributed to contribute considerably to the regenerative medicines market growth across the globe

Changing environmental conditions with increasing penetration of ultraviolet rays to the earth's surface due to global warming consequently impacting the human health by causing oncologic and dermatology based diseases is attributed to create an upsurge in demand for regenerative medicines during the forthcoming years. Additionally, increasing exposure of the present population to X-rays and gamma rays due to high nuclear energy involving practices is increasing incidences of cancer, subsequently propelling the regenerative medicines market across North America.

A sharp reduction in the size of secondary care institutions across Europe in the past decade has resulted in the streamlining of healthcare delivery and stimulated more efficient and integrated model of care that is anticipated to lead to complete conquer of the hospital-centric pattern of care over the forthcoming years. These change in patterns of healthcare are attributed to influence the regenerative medicines market positively across Europe

Increasing prevalence of diabetes retinopathy with rising cases of diabetes mellitus across Asia has resulted in rise in adoption of regenerative medicines for cornea regeneration and other ophthalmic applications driving the market subsequently in the continent over the past. Besides, new application discoveries in the field of regenerative medicines through extensive research and development activities across the countries of India, Japan and China are anticipated to boost the market positively during the forecast period

Table of Contents

Introduction

  • Market Definition
  • Product Definition
  • Research Objective
  • Research Methodology

Executive Summary

Market Dynamics of Global Regenerative Medicines Market

  • Market Drivers
  • Market Challenges
  • Market Trends
  • Opportunities

Global Regenerative Medicines Market

  • Market overview - market size and forecast (2018-2027)

Market segmentation by:

  • Technology
  • Source
  • Applications
  • End-Users
  • U.S Regenerative Medicines Market

Market overview - market size and forecast (2018-2027)

Market segmentation by:

  • Technology
  • Source
  • Applications
  • End-Users
  • Europe Regenerative Medicines Market

Market overview - market size and forecast (2018-2027)

Market segmentation by:

  • Country
  • Technology
  • Source
  • Applications
  • End-Users
  • Industry Analysis

Policy & regulatory landscape

Risk analysis

  • Competitive Landscape

Company Profiles of top players

Back to Top